​Breast

• (152-17) A Modular Phase I, Open-Label, Multicentre Study to Assess Ascending Doses of AZD6738 in Combination With Chemotherapy and/or Novel Anti Cancer Agents (Phase 1 clinical trial, appropriate for patients with advanced solid malignancies of the breast.)

• (187-17) Phase 1 trial of ZW25 in patients with locally advanced (unresectable) and/or metastatic HER2-expressing cancers (Phase 1 clinical trial, appropriate for patients with HER2 expressing cancers.)